People
In an in-depth investigation, STAT reported on behind-the-scenes activities at the Second International Summit on Human Genome Editing at the University of Hong Kong, where He made his announcement.
Rentschler Biopharma SE, announced that Dr. Jesús Zurdo will join the company as Senior Vice President Process Science and Innovation, effective January 01, 2019.
Charles Morris, chief medical officer for Waltham, Mass.-based Radius Health, is eying the day that there will be better outcomes for breast cancer patients who have developed tumors resistant to current treatments. If things continue to go well, Radius may be able to provide those options.
With the year closing out, biotech and pharma companies are making adjustments to their leadership ranks and boards of directors.
In writing literally hundreds of stories this year, two BioSpace writers, Alex Keown and Mark Terry, found certain stories particularly intriguing or impactful. Some of those were such big topics that they were covered over a series of stories. Looking back at 2018, here are their Top 10.
CARMAT today announces the appointment of Pascale d’Arbonneau as Chief Financial Officer.
As we look back over the year, we noticed some stories just grabbed readers more than others. Here’s a look at the top 10 stories of the year, including job cuts, best-selling drugs, up-and-coming companies,scandals, clinical trials, and more.
Microsoft co-founder Paul Allen set aside $125 million to fund a new division at a scientific institute he founded to focus on understanding the immune system. This morning, it was reported that the Allen Institute is expanding.
Technology is constantly impacting and changing the way the world works. Greater technological innovations are not only changing the way business operate, but also have significant impact on employees.
Gilead Sciences officially announced that long-time Roche veteran, Daniel O’Day, will assume the helm of the company as chairman and chief executive officer beginning March 1. O’Day takes over for John Milligan, who announced his plans to retire by the end of the year in July.
PRESS RELEASES